Abstract:Background
Tyrosine Kinase Inhibitors (TKI) are the standard treatment for Philadelphia chromosome positive chronic myeloid leukaemia (Ph + CML). Imatinib is also indicated for Kit- (CD117) positive metastatic malignant gastrointestinal stromal tumours.
The high rates of survival obtained in recent years have turned these diseases into chronic conditions. Thus, adherence to treatment is hugely important.
Many studies have shown that low adherence to treatment with imatinib (<85–90%) is related to a loss of cyt… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.